stockrow
Friday 6 November 2026
Export INMD’s income statement to Excel — free account
InMode Ltd.
INMD Healthcare Medical Devices
InMode Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $370.5 million, down 6.16% from fiscal 2024.
- Revenue
- −0.01%
- EPS
- −31.0%
- Free cash flow
- −12.6%
Quarter to June 2026, against a year earlier
13.35
0.05
−0.37%
Follow INMD
Alert me
InMode Ltd. (INMD) P/E ratio
As of 5 November 2026, InMode Ltd. (INMD) trades at a P/E ratio of 10.7×. Over the past ten years it has ranged from 5.5× (July 2025) to 53.6× (September 2021); the current reading is higher than 37% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 10.1× | 42.79% |
| FY2024 | 7.0× | (24.53%) |
| FY2023 | 9.3× | (48.10%) |
| FY2022 | 18.0× | (48.77%) |
| FY2021 | 35.1× | 50.87% |
| FY2020 | 23.3× | 22.83% |
| FY2019 | 18.9× | 77.79% |
| FY2018 | 10.7× | 0.00% |
| FY2017 | 10.7× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 11.7× | 17.99% |
| Mar 2026 | 9.9× | (1.48%) |
| Dec 2025 | 10.1× | 47.21% |
| Sep 2025 | 6.8× | 17.86% |
| 30 more quarters | Free account |
Against its own ten years
Low 5.5×
High 53.6×
Ten-year median
14.2×
Current reading's percentile
37
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PACB Pacific Biosciences of California, Inc. compare | n/m |
| CTKB Cytek Biosciences, Inc. compare | n/m |
| BBNX Beta Bionics, Inc. compare | n/m |
| AHCO AdaptHealth Corp. compare | n/m |
| QDEL QuidelOrtho Corporation compare | n/m |
| KIDS OrthoPediatrics Corp. compare | n/m |
| INMD InMode Ltd. | 10.7× |
| BVS Bioventus Inc. compare | 12.3× |
| VREX VAREX IMAGING compare | 34.8× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)